- Pre-assessment
-
Pre-course assessment
The pre-test is required to access the educational material.
- Review Course Materials
-
Using Family History to Inform Management
Contains the educational material.
- Post Quiz & Evaluation
-
Post-course assessment
Passing the post-test is required to earn a certificate.
-
Evaluation
-
Accessing your certificate
-
Resources
The resources and references are the same as found in the course material.
-
Tools & resources
Additional resources for more learning about genomic tumor testing
-
More education
-
References
References used to develop the content
Using Family History to Inform Management (CME)
Practice determining appropriate management for a patient based on family history risk stratification.
Family history information can help guide management decisions no matter what level of risk a patient has. Guidelines exist for using family history information to make management decisions. In this course, you will practice determining appropriate management based on family history risk.
To claim credit, follow the steps in the learning path.
CME Information and Disclosures
Jointly Provided by The Jackson Laboratory and the University of Connecticut School of Medicine Office of Community and Continuing Medical Education
Original Release: April 24, 2014
Renewal Date: July 1, 2023
Expiration Date: June 30, 2026
Learning Objectives
- Develop an appropriate management plan based on personal and family history assessment.
Target Audience
Practicing primary care providers as well as students and residents.
Accreditation
The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 2 out of 4 questions correctly and 4) complete the evaluation.
Conflict of Interest Policy
All faculty members participating in CME activities sponsored by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.
Planners, Writers, and Reviewers
- Emily Edelman, MS, CGC – The Jackson Laboratory
- Therese Ingram, MA – The Jackson Laboratory
- Kalisi Logan, MS, CGC – The Jackson Laboratory
- Kate Reed, MPH, ScM, CGC – The Jackson Laboratory
- Linda Steinmark, MS, CGC – The Jackson Laboratory
- Hayley Dunnack Yackel, PhD, RN, CMSRN, OCN – Hartford Healthcare Cancer Institute
- Fatima Amir, MS, CGC - Genome Medical
Disclosure Statement
The activity director, the co-activity director, planning committee, writers and reviewers for this educational event have no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that needs to be disclosed. This educational event will not be discussing the off-labeled or investigational use of any product or device.
Actors are being used in this program and are presenting information that has been scripted for them. They were not involved with the educational content of this activity.
Commercial Support
This CME activity has no commercial support associated with it.
References
Berliner JL, Cummings SA, Boldt Burnett B, Ricker CN. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors. J Genet Couns. 2021; 30(2):342-360.
Grossman DC, Curry SJ, Owens DK, et al. Screening for Prostate Cancer. JAMA. 2018; 319(18):1901-.
Gupta N, Kupfer SS, Davis AM. Colorectal Cancer Screening. JAMA. 2019; 321(20):2022-.
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Detection, Prevention and Risk Reduction. (Requires free registration).
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116(3):458-479.
Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016; 164(4):279-.
Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210.
Wei JT, Barocas D, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. J Urol. 2023;210(1):46-53.
Wei JT, Barocas D, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy. J Urol. 2023;210(1):54-63.
Hardware/Software Requirements
Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher
Check the supported browsers.
Should you have technical questions or questions regarding the content of the activity, please email Clinical Education at the Jackson Laboratory.
Disclaimer
All information in Cancer Genetic Clinical Education is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Cancer Genetic Clinical Education. Reliance on any information in Cancer Genetic Clinical Education is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Cancer Genetic Clinical Education.